Form 4: Heartflow Director Sells Shares Under 10b5-1 Plan

Heartflow Director Julie A Cullivan sold 9,122 shares of common stock for $25 per share, reducing her direct beneficial ownership to 27,291 shares.

Summary

• Julie A Cullivan, a Director at Heartflow, Inc. (HTFL), reported a sale of common stock.
• The transaction involved the disposition of 9,122 shares of Heartflow common stock.
• The shares were sold at a price of $25 per share.
• Following this transaction, Julie A Cullivan directly beneficially owns 27,291 shares of common stock.
• The sale was executed on March 5, 2026, pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was pre-planned under a 10b5-1 plan, which typically suggests a scheduled liquidity event for the director rather than a reaction to new company-specific information, thus not strongly impacting sentiment.

Negatives

• A director selling shares could be perceived negatively by some investors, although this sale was pre-planned.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 trading plan, are a routine part of executive compensation and personal financial management. While all insider transactions are scrutinized by investors for potential signals, sales under pre-arranged plans are generally viewed as less indicative of management's immediate sentiment about the company's prospects compared to open market, unplanned sales.

Stakeholder Impact

• Shareholders may note the reduction in a director's direct ownership stake, though the pre-planned nature of the sale mitigates concerns about management's confidence.

Key Dates

Recommendation

The sale by a director was executed under a pre-arranged 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a change in sentiment about the company's future prospects. Therefore, it does not provide a strong signal for a change in investment strategy, warranting a 'hold' recommendation.

Keywords

Heartflow, HTFL, Form 4, Insider Trading, Stock Sale, Director, Julie A Cullivan, 10b5-1 Plan